A novel 21-kDa cytochrome c-releasing factor is generated upon treatment of human leukemia U937 cells with

Yutaka Masuda1, Sayoko Maeda, Akiko Watanabe

  • 1Laboratory of Biological Chemistry, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan.

Insights

Geranylgeraniol (GGO) triggers cancer cell death via mitochondria. Researchers identified a key protein, cytochrome c-releasing factor 21 (CRF21), responsible for this GGO-induced apoptosis in leukemia cells.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Geranylgeraniol (GGO) is known to induce apoptosis in human tumor cells.
  • The precise molecular mechanisms underlying GGO-induced apoptosis, particularly involving mitochondrial pathways, require further elucidation.

Purpose of the Study:

  • To identify and characterize factors involved in GGO-induced apoptosis in human leukemia U937 cells.
  • To investigate the role of a specific protein in cytochrome c release from mitochondria.

Main Methods:

  • Treatment of U937 leukemia cells with GGO.
  • Analysis of cytosolic fractions for protein factors.
  • Cell-free system using isolated mitochondria and cell lysates.
  • Protein purification and characterization.
  • Overexpression studies in HeLa cells.

Main Results:

  • A 21-kDa protein, designated cytochrome c-releasing factor 21 (CRF21), was identified in the cytosolic fraction of GGO-treated U937 cells.
  • CRF21 was found to induce the release of cytochrome c from isolated mitochondria.
  • Overexpression of CRF21 in HeLa cells led to cytochrome c release and subsequent apoptosis.
  • CRF21 appears to be a key mediator of GGO-induced apoptosis.

Conclusions:

  • CRF21 is a novel protein that induces cytochrome c release from mitochondria.
  • CRF21 plays a significant role in the GGO-induced apoptotic pathway in leukemia U937 cells.
  • CRF21 may represent a therapeutic target for GGO-based cancer treatments.